TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/05 15:20 | 5/25/05 | BSTE | Biosite Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Watlington Thomas M | CA | O | EVP,COO | S.d | -1,319 | 65.03 | 0 | -20 | -97 | 1 | D | ||||||||||||||
2/14/05 19:23 | 2/10/05 | BSTE | Biosite Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Watlington Thomas M | CA | O | EVP,COO | S.d | -364 | 60.75 | 0 | -6 | -90 | 1 | D | ||||||||||||||
2/14/05 19:22 | 2/10/05 | BSTE | Biosite Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Watlington Thomas M | CA | O | EVP,COO | S | -1,257 | 60.11 | 0 | -21 | -97 | 1 | D | ||||||||||||||
2/3/05 19:39 | 2/2/05 | BSTE | Biosite Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Watlington Thomas M | CA | O | EVP,COO | S.d | -360 | 60.00 | 0 | -6 | -90 | 1 | D | ||||||||||||||
1/31/05 14:32 | 1/28/05 | BSTE | Biosite Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Watlington Thomas M | CA | O | EVP,COO | S.d | -1,949 | 55.86 | 0 | -35 | -98 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |